Celltrion’s Covid-19 drug shows therapeutic efficacy in Phase II trials
South Korean company Celltrion has reported data from Phase II clinical trials confirming that its...
Celltrion concludes enrolment in global Covid-19 antibody trial
Celltrion Group has completed enrolment of 327 patients with mild-to-moderate SARS-CoV-2 infection symptoms to evaluate...
Celltrion’s antibody candidate aids faster recovery in Covid-19 trial
Celltrion has announced that results from the ongoing Phase I trial showed the monoclonal antibody...
Celltrion gets approval to trial antibody-based Covid-19 treatment
Celltrion Group has received approval from the Korean Ministry of Food and Drug Safety (MFDS)...
Celltrion starts Phase I Covid-19 trial of antibody candidate
Celltrion Group has initiated a Phase I clinical trial of its investigational antiviral antibody candidate...
IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea
The International Vaccine Institute (IVI) and Seoul National University (SNU) Hospital have partnered to conduct...
Neo and FLETA collaborate on trial data registry platform launch
Korean-based project FLETA has formed a strategic collaboration with Chinese blockchain giant Neo on the...
Inovio gets grant to partner with IVI and KNIH for Covid-19 vaccine
Inovio Pharmaceuticals has received $6.9m in funding from the Coalition for Epidemic Preparedness Innovations (CEPI)...
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of...
Coronavirus in South Korea: COVID-19 outbreak, measures and impact
Neighbouring two coronavirus-affected countries China and Japan, South Korea is among the top ten countries...